Location: Home
  • search
  • go
  • Relate News
  • 9/12/2022WuXi STA Opens a New Sterile Lipid Nanoparticle Formulation Facility t...
  • 9/12/2022CFIUS Derails Asymchem's Acquisition of Snapdragon
  • 8/30/2022RoosterBio and MBL Beijing Biotech Partner to Accelerate Advanced Ther...
  • 8/17/2022WuXi STA Breaks Ground for 2nd Drug Manufacturing Facility in the U.S.
  • 8/5/2022CNIPA Rules In Favor of Boehringer in First Important Patent Infringem...
  • 7/21/2022WuXi Biologics Plans to Build a Comprehensive CRDMO Center in Singapor...
  • 7/19/2022WuXi STA Opens a New Large Scale Continuous Manufacturing Plant
  • 7/19/2022WuXi AppTec Plans to Build a New Site in Singapore with Planned S$2B I...
  • 7/7/2022Pharmaron Acquires Commercial API Manufacturing Facility in the U.S.
  • 7/1/2022Eurofins DiscoverX Establishes A New China Biotechnology Office
  • 6/29/2022WuXi STA Opens Another High-Potency API Plant In Changzhou
  • 6/6/2022WuXi Biologics Launches First Commercial Drug Product Facility for Pre...
  • 6/3/2022NeoGenomics's Suzhou Pharma Services Lab Gets CAP Certification
  • 5/24/2022Vir and WuXi Bio Terminate COVID Antibody Agreement
  • 5/23/2022Fujifilm Completes Construction of Bioprocessing Innovation & Collabor...
  • 5/23/2022Biopharma in China: The Emerging Global Force of Domestic Suppliers
  • 4/28/2022Stevanato Group Acquires Manufacturing Facility in Zhejiang to Suppor...
  • 4/18/2022VectorBuilder to Build $500M Gene Therapy Manufacturing Facility in Ch...
  • 4/11/2022Decentralized CRO Science 37 Expands in the Asia-Pacific including Chi...
  • 4/7/2022The Chinese Pharma CMO Market to Reach $13B in 2030, Predicts Roots An...
  • 4/7/2022CDMO Asymchem Completes Expansion of  Chinese Manufactuing Facilitie...
  • 3/11/2022Pharma CMO Stevanato Group Expands Capacity in China with New Facility
  • 3/9/2022Lonza Expands API Development and Manufacturing Laboratories in Nansha
  • 3/3/2022WuXi STA Passes the First EMA Drug Product Pre-Approval Inspection at ...
  • 2/14/2022Chinese CDMO Asymchem to Expand in the U.S. thru Acquisition of Snapdr...
  • 1/23/2022WuXi STA Opens Its First Parental Formulation Manufacturing Line
  • 1/13/2022FUJIFILM Irvine Scientific Plans Bioprocessing Center in China
  • 12/6/2021Fujifilm Irvine Scientific Establishes Innovation Center in China
  • 12/2/2021WuXi STA and Coherent Biopharma Forms Strategic Partnership 
  • 11/23/2021Ji Xing Granted Chinese IND Approval for Phase 1 & 3 Trials of Etripam...
  • Page:3/18 Total number of articles:517: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group